WeVote
Log In

Bill

Bill

SB 134

Medicare Supplement Policies - Issuance - Requirements

2026 Regular Session

Maryland SB 134 establishes new issuance requirements for Medicare supplement insurance policies, affecting how insurers market and underwrite Medigap coverage to seniors.

Approved by the Governor - Chapter 140
0
WeVote Research Nonpartisan
Bill Summary · SB 134

Legislative bill overview

SB 134 modifies Maryland's regulations governing the issuance of Medicare supplement (Medigap) insurance policies. The bill establishes new requirements for insurers offering these supplemental plans to Medicare beneficiaries, likely addressing underwriting standards, policy terms, or consumer protections in this market segment.

Why is this important

Medicare supplement policies are critical for seniors managing healthcare costs not covered by original Medicare. Changes to issuance requirements can affect insurance availability, affordability, and consumer protections for Maryland's approximately 900,000+ Medicare beneficiaries, while also impacting insurers' business operations in the state.

Potential points of contention

  • Insurer compliance costs: New issuance requirements may increase administrative burdens and compliance expenses that insurers could pass to consumers through higher premiums
  • Market availability: Stricter requirements could discourage some insurers from offering Medigap policies in Maryland, potentially reducing consumer choice in certain geographic areas
  • Scope ambiguity: Without bill text details, unclear whether requirements address pre-existing condition limitations, guaranteed issue periods, rate restrictions, or other specific protections that could significantly impact different stakeholder groups

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.